Paul Hastings, a leading global law firm, announced today that the firm advised Edmond de Rothschild Capital Partners (EdRCP) on the leveraged buy-out of French medical equipment company, Groupe Moria, a leading European specialist in the design and manufacture of surgical instruments for use in ophthalmology and orthopedics, in order to take the company private.
The EdRCP managed investment fund, Edmond de Rothschild LBO Fund II (ERLF II), became the indirect majority shareholder of newly created holding company, Financière Cronos SAS, which acquired 1,942,117 Moria SA shares (85.27% of the share capital) from Altamo SAS (68.86% shareholder of Moria SA) and several other shareholders, including Siparex and MMA Participations.
Together with ERLF II, the management of Groupe Moria also made a significant reinvestment in the buyout. Financière Cronos SAS has made a voluntary share buy-back offer, running from 22 September 2011 to 26 October 2011, to acquire the remaining Moria SA shares from minority shareholders. (Moria SA shares are publicly traded on the Free Market (Marché Libre) of NYSE Euronext Paris).
The Paul Hastings team which advised EdRCP was led by partners, Alexis Terray
and Mounir Letayf
, assisted by associates, Sébastien Crepy
and Camille Bakouch
. Specifically, Alexis Terray and Sébastien Crépy advised on the equity part of the deal, and Mounir Letayf, Camille Bakouch advised on debt. Paul Hastings is a leading global law firm with offices in Asia, Europe, and the United States. We provide innovative legal solutions to financial institutions and Fortune 500 companies. Please visit www.paulhastings.com for more information.